Breaking News Bar

Business News and Information

Targeting Parkinson's, Peninsula drug maker nabs $60M to continue Roche partnership

The companies will take a potential antibody treatment for Parkinson's — whose high-profile patients have included Muhammad Ali and Michael J. Fox — into a Phase IIb trial.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear